Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0675
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.005 (7.692%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.0675
RBD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

29 Jan 2010 07:00

RNS Number : 3069G
Adventis Group PLC
29 January 2010
 



29 January 2010

Adventis Group Plc

("Adventis", the "Group" or the "Company")

Trading Statement 

Adventis Group plc (Adventis - ATG), the AIM-quoted full service multimedia marketing and advertising agencyannounces the following trading update for the year ended 31 December 2009.

Results for the year ended 31 December 2009 are expected to be in line with market expectations. All divisions of the Group traded profitably in 2009 and considerable further economies were achieved, the benefits of which will be reflected fully in 2010.

 

The current year has started with an improved visibility of sales in most divisions and the Board anticipates a better year for the Group. The Board will continue to pursue appropriate M&A opportunities in 2010, supported by the additional institutional investment made in Q4 2009.

Adventis expects to announce its preliminary results for the year ended 31 December 2009 towards the end of March 2010

CONTACT: 

Adventis Group Plc

www.adventis.co.uk

Charles Phillpot, CEO

020 7034 4750

Peter Linnell, Finance Director 

020 7034 4795

Peckwater PR

Tarquin Edwards

Chris Steele 

07879 458 364

07979 604 687 

Arbuthnot Securities Limited

Tom Griffiths

020 7012 2000

Notes to Editors:

Adventis Group is a marketing services and advertising agency. Its core areas of activity are healthcare, technology & telecoms, media and property. Subsidiary companies include: Adventis Health, Second2, Adventis Media, Adventis Digital and Adventis Property. For full details see www.adventis.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQVLFLBFFZBBE
Date   Source Headline
4th Nov 20226:22 pmRNSResponse to Presentation from Requisitioners
2nd Nov 20227:00 amRNSInvestor Presentation
1st Nov 20221:15 pmRNSCompletion of the Sale of Corallian to Shell
31st Oct 20229:08 amRNSPosting of Circular and Notice of Requisitioned GM
31st Oct 20227:00 amRNSPosting of Circular and Notice of Requisitioned GM
20th Oct 20227:00 amRNSRequisition of General Meeting
17th Oct 20221:00 pmRNSPurported Requisition of General Meeting
5th Oct 20223:30 pmRNSSPA for Sale of Corallian to Shell for £32 million
30th Sep 20227:00 amRNSUnaudited HY Results for 6 months ended 30/06/22
29th Sep 20227:02 amRNSPublication of PEDL183 CPR by RPS Energy
28th Sep 20227:00 amRNSConditional Acquisition of Simwell Resources
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
23rd Sep 20227:00 amRNSWest Newton Community Update on Planned Activity
15th Sep 20227:00 amRNSAcquisition of North Sea Assets from Corallian
14th Sep 20227:00 amRNSAgreed Terms of Conditional Sale of Corallian
9th Sep 20224:40 pmRNSSecond Price Monitoring Extn
9th Sep 20224:35 pmRNSPrice Monitoring Extension
9th Sep 20227:00 amRNSResponse to Governmental Energy Plan
1st Sep 20227:00 amRNSUpdate on Corallian and acquisition of licences
14th Jul 20221:56 pmRNSHolding(s) in Company
1st Jul 20227:00 amRNSBoard Change
29th Jun 20224:31 pmRNSResults of Annual General Meeting
23rd Jun 20227:00 amRNSInvestor Presentation
21st Jun 20227:00 amRNSWest Newton Conceptual Development Plan
7th Jun 202211:53 amRNSNotice of AGM – correction of typographical error
1st Jun 202210:06 amRNSNotice of Annual General Meeting
27th May 20227:00 amRNSFull Year Results for the year ended 31 Dec 2021
26th May 20227:00 amRNSCompletion of Equity Exchange Agreement
24th May 20227:00 amRNSReabold North Sea – Presentation on New Licences
23rd May 20227:00 amRNSShareholder Approval Received for Equity Exchange
13th May 20227:00 amRNSAppointment of Chief Financial Officer
4th May 20227:00 amRNSOffer for Corallian and acquisition of licences
3rd May 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
17th Mar 202212:21 pmRNSPlanning Application Approval for Next Phase
25th Feb 20227:00 amRNSInvestor Presentation
25th Feb 20227:00 amRNSUpdate on Equity Exchange with Daybreak Oil & Gas
24th Feb 20224:42 pmRNSSecond Price Monitoring Extn
24th Feb 20224:37 pmRNSPrice Monitoring Extension
17th Feb 202212:38 pmRNSAmendment of Existing Option Terms
25th Jan 20229:05 amRNSSecond Price Monitoring Extn
25th Jan 20229:00 amRNSPrice Monitoring Extension
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
17th Jan 20227:00 amRNSWest Newton Flow Rate Update
23rd Dec 20217:00 amRNSVictory – Submission of Draft FDP
2nd Dec 20212:00 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSWest Newton – Rathlin’s Update to Residents
22nd Oct 20217:00 amRNSDirectors’ Dealings
21st Oct 20217:00 amRNSCreation of Enhanced California E&P Company
20th Oct 202111:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.